These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7969632)

  • 1. [Paradoxical blood pressure increases during increased sympathetic activity with the administration of non-beta 1-specific beta blockers].
    Cleophas AJ; Kauw FH
    Ned Tijdschr Geneeskd; 1994 Nov; 138(47):2337-40. PubMed ID: 7969632
    [No Abstract]   [Full Text] [Related]  

  • 2. [Symptoms and cardiovascular complications of the withdrawal of beta-blocker treatment. Practical implications].
    Plouin PF
    Therapie; 1984; 39(4):379-90. PubMed ID: 6148791
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of the sympathetic system in experimental and human hypertension.
    De Champlain J; Cousineau D; Van Amerigen MR; Marc-Aurèle J; Yamaguchi N
    Postgrad Med J; 1977; 53 Suppl 3():15-30. PubMed ID: 22071
    [No Abstract]   [Full Text] [Related]  

  • 4. Pressor responses from noncardioselective beta-blockers.
    Cleophas TJ; Kauw FH
    Angiology; 1988 Jul; 39(7 Pt 1):587-96. PubMed ID: 2900614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autonomic degeneration and altered blood pressure control in humans.
    Ziegler MG; Lake CR
    Fed Proc; 1984 Jan; 43(1):62-6. PubMed ID: 6317464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increasing longevity by decreasing sympathetic stress--early beta receptor blockade pharmacotherapy.
    Milne B; Hong M
    Med Hypotheses; 2004; 62(5):755-8. PubMed ID: 15082101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of doxazosin on ambulatory blood pressure and sympathetic nervous activity in hypertensive Type 2 diabetic patients with overt nephropathy.
    Yasuda G; Hasegawa K; Kuji T; Ogawa N; Shimura G; Umemura S; Tochikubo O
    Diabet Med; 2005 Oct; 22(10):1394-400. PubMed ID: 16176202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The sympathetic nervous system and ischaemic heart disease.
    Remme WJ
    Eur Heart J; 1998 Jun; 19 Suppl F():F62-71. PubMed ID: 9651738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basic autonomic nervous function in patients with neurocardiogenic syncope.
    Saito F; Imai S; Tanaka N; Tanaka H; Suzuki K; Takase H; Aoyama H; Matsudaira K; Ebuchi T; Akamine Y; Takahashi N; Sugino K; Kanmatsuse K; Yagi H; Kushiro T
    Clin Exp Hypertens; 2007 Apr; 29(3):165-73. PubMed ID: 17497343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-blockers in the treatment of hypertension: are there clinically relevant differences?
    Weir MR
    Postgrad Med; 2009 May; 121(3):90-8. PubMed ID: 19491545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morning blood pressure surge and hypertensive cerebrovascular disease: role of the alpha adrenergic sympathetic nervous system.
    Kario K; Pickering TG; Hoshide S; Eguchi K; Ishikawa J; Morinari M; Hoshide Y; Shimada K
    Am J Hypertens; 2004 Aug; 17(8):668-75. PubMed ID: 15288883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-blocking agents with vasodilator activity.
    Rosendorff C
    J Hypertens Suppl; 1993 Jun; 11(4):S37-40. PubMed ID: 8104240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of antihypertensive therapies on the sympathetic nervous system.
    de Champlain J; Karas M; Toal C; Nadeau R; Larochelle P
    Can J Cardiol; 1999 Mar; 15 Suppl A():8A-14A. PubMed ID: 10205251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihypertensive agents which inhibit sympathetic activity: potentially adverse effects of combination treatment.
    Drayer JI; Weber MA
    Am Heart J; 1982 Sep; 104(3):660-4. PubMed ID: 6126112
    [No Abstract]   [Full Text] [Related]  

  • 15. Yohimbine administration prevents over-responsiveness to epinephrine induced by simulated microgravity.
    Berlan M; Verhaeghe S; Pavy-Le Traon A; Thalamas C; Lafontan M; Marques MA; Senard JM; Parent M; Galitzky J
    Aviat Space Environ Med; 2002 Aug; 73(8):735-42. PubMed ID: 12182212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Beta blockers in the treatment of arterial hypertension].
    Spinar J; Vítovec J
    Cas Lek Cesk; 1998 May; 137(9):278-81. PubMed ID: 9650357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are blood pressure surges associated with sympathetic stimulation aggravated by beta-adrenoceptor antagonist treatment?
    Kumana CR
    Postgrad Med J; 1986 Aug; 62(730):731-5. PubMed ID: 2877453
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of calcium antagonists on sympathetic activity.
    Grossman E; Messerli FH
    Eur Heart J; 1998 Jun; 19 Suppl F():F27-31. PubMed ID: 9651732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sympathetic activation triggers endogenous opioid release and analgesia within peripheral inflamed tissue.
    Binder W; Mousa SA; Sitte N; Kaiser M; Stein C; Schäfer M
    Eur J Neurosci; 2004 Jul; 20(1):92-100. PubMed ID: 15245482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sympathetic nervous factors, pressure variability and organ damage in arterial hypertension].
    Mancia G; Seravalle G; Grassi G
    Ann Ital Med Int; 1997; 12(4):217-22. PubMed ID: 9773576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.